American Biogenetic Sciences, Inc. Stock Other OTC
Equities
US0246113031
Healthcare Facilities & Services
End-of-day quote
Other stock markets
|
||
- USD | - |
Financials (USD)
Sales 2022 | 1.24 | Sales 2023 | 1.41 | Capitalization | 876K |
---|---|---|---|---|---|
Net income 2022 | -1M | Net income 2023 | - | EV / Sales 2022 | 2,435,468 x |
Net Debt 2022 | 1.5M | Net Debt 2023 | 1.73M | EV / Sales 2023 | 1,849,662 x |
P/E ratio 2022 |
-1.48
x | P/E ratio 2023 |
-1.81
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 67.18% |
Managers | Title | Age | Since |
---|---|---|---|
Troy Grogan
CEO | Chief Executive Officer | 47 | 15-05-26 |
Olivia Giamanco
IRC | Investor Relations Contact | - | - |
Corporate Officer/Principal | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Troy Grogan
CEO | Chief Executive Officer | 47 | 15-05-26 |
1st Jan change | Capi. | |
---|---|---|
+14.71% | 80.61B | |
-29.72% | 70.18B | |
+9.86% | 29.12B | |
-11.49% | 16.97B | |
-0.78% | 16.96B | |
-0.51% | 15.26B | |
+4.03% | 12.41B | |
-30.88% | 11.95B | |
-5.18% | 11.93B |